NCT01645917View on ClinicalTrials.gov

Durability of Pulmonary Vein Isolation Following Cryoablation for Treatment of Paroxysmal Atrial Fibrillation

PHASE4CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

November 30, 2013

Conditions
Paroxysmal Atrial Fibrillation
Interventions
DEVICE

Arctic Front Advance Cardiac CryoAblation system

Standard of care ablation for indicated paroxysmal AF patients with Medtronic's Arctic Front Advance Cardiac CryoAblation system

Trial Locations (1)

Unknown

Homolka Hospital, Prague

All Listed Sponsors
collaborator

Medtronic International Trading Sarl

INDUSTRY

lead

Medtronic Cardiac Rhythm and Heart Failure

INDUSTRY

NCT01645917 - Durability of Pulmonary Vein Isolation Following Cryoablation for Treatment of Paroxysmal Atrial Fibrillation | Biotech Hunter | Biotech Hunter